Good tolerability: Side effects were generally mild and included injection site reactions, headache, and diarrhea
Analysis of the available research reports that tirzepatide administered at 15mg/weekly may result in a hazard ratio (HR) of 0.8 for the incidence of cardiovascular events
Wegovy and Ozempic are brand names of semaglutide, and since its widespread introduction for weight loss, patients and doctors have seen that the drug appears to curb addictive tendencies beyond overeating
Key Considerations Compounded semaglutide is not equivalent to FDA-approved semaglutide products Safety, efficacy, and quality may vary among compounded formulations Use requires medical supervision and ongoing monitoring Cost, availability, and formulation differ depending on the pharmacy and prescription Patients should discuss FDA-approved options, compounded alternatives, potential risks, and expected outcomes with their healthcare provider before starting treatment
Even if you regain some weight, you may still weigh considerably less than you did when you started treatment